Bring foot and ankle experts to your home or office with Instructional Course Lectures! Recorded at AOFAS Annual Meeting 2021, these presentations take an in-depth look at clinical challenges and best practices in foot and ankle orthopaedic surgery. 

Topics Included:

• Moderator: Carroll P. Jones III, MD
  
  • Avoiding Surgery If You Can - Vinod K. Panchbhavi, MD
  • Failed, Not Fused, and Maybe Infected - W. Hodges Davis, MD
  • The Infected Midfoot: Frame... Period - Michael S. Pinzur, MD
  • Ankle/Hindfoot: Nail It? Frame It? Both? - Clayton C. Bettin, MD
  • Midfoot: All Clean and All In - Carroll P. Jones III, MD
  • The Infected Charcot Foot: Management Strategies - Veerabhadra K. Reddy, MD
  • Discussion

• Moderator: Michael J. Coughlin, MD
  
  • 1st TMT Fusion: Fad, Fiction, or Fact? - Robert D. Santrock, MD
  • The Painful Implant: What Now? - Scott B. Shawen, MD
  • Complex/Salvage 1st Ray Surgery - Joseph S. Park, MD
  • Debate: Metatarsal Osteotomy - Donald R. Bohay, MD; Michael J. Coughlin, MD
  • Lesser MTP Instability: The Holy Grail - Jesse F. Doty, MD
  • Frieberg’s and Lesser MTP Arthrosis: Do We Have Any Answers Yet? - Jason T. Bariteau, MD
  • Discussion

• Moderator: Robert B. Anderson, MD
  
  • Ankle Instability: When Is Enough Not Enough? - J. Kent Ellington, MD, MS
  • Turf Toe and Sesamoid Problems - Kenneth J. Hunt, MD
  • Navicular Stress Fractures: Fix Now, Fix Later, Fuse Inevitable -Jeremy J. McCormick, MD
  • Peroneal Tears and Tendinopathy - Steven K. Neufeld, MD
  • 5th Metatarsal Fractures: What’s the Latest, Sir Robert? - David A. Porter, MD, PhD
  • Stress Fractures in the Athlete: Treating More Than Just the Bone - Gregory R. Waryasz, MD
  • Discussion

• Moderator: Gregory P. Guyton, MD
  
  • The Physical Exam and a Neurology Update - Gregory P. Guyton, MD
  • The Subtle Cavovarus Foot - J. Chris Coetzee, MD
  • Severe Cavovarus Deformity: Fusion vs. Joint Sparing vs. Little Bit of Both - Paul T. Fortin, MD
  • Addressing the Cavovarus Foot with Ankle OA - Karl M. Schweitzer Jr., MD
  • The Failed Cavovarus Foot Reconstruction:How Do I Salvage It? -David B. Thordarson, MD
  • Discussion

• Moderator: Rebecca A. Cerrato, MD
  
  • How You Get Started - Jonathan R.M. Kaplan, MD
  • MIS Hallux Valgus - Oliver N. Schipper, MD
  • MIS Calcaneal Osteotomies - Ettore Vulcano, MD
  • MIS Lesser Toes - A. Holly Johnson, MD
  • Mama Said There Would Be Days Like This:Managing MIS Complications - Jorge I. Acevedo, MD
  • MIS Potpourri - Christopher P. Miller, MD
  • Discussion

• Moderator: Mark E. Easley, MD
  
  • To Stage or Not to Stage? That Is the Question - Steven L. Haddad, MD
  • A Failed TAR Is Not a Failure - W. Hodges Davis, MD
  • TAR to Fusion, Fusion to TAR: How, When, and Why? - William C. McGarvey, MD
  • Balancing the TAR and Why It’s Critical - Craig S. Radnay, MD, MPH
  • Need Me Now, Later, or Never? - Ryan M. Garcia, MD
  • My TAR Looks Great, but My Patient Still Hurts - Lew C. Schon, MD
  • Discussion

• Moderator: Bruce E. Cohen, MD
  
  • Overview: Healthcare 2021 and Beyond - Bruce E. Cohen, MD
  • Coding, Documentation, and More - Gregory T. Ardoin, MD
  • Working with Companies: You and Industry - Gregory C. Berlet, MD
  • Debate: Types of Practice - Employed vs. Independent - John T. Campbell, MD; Raymond J. Sullivan, MD
  • Practice and ASC Optimization - R. James Toussaint, MD
  • Managing Conflict: Patient and MD - Casey J. Humbyrd, MD
  • Discussion

• Moderator: Clifford L. Jeng, MD

• • Conservative Treatment: What Works and What Doesn’t - Irvin Oh, MD
  • Flexible Deformity: Which Procedures and Why? - Clifford L. Jeng, MD
  • Stage IV Flatfoot Management - Mark S. Myerson, MD
  • New Calcaneal and Midfoot Osteotomies - Keith L. Wapner, MD
  • Reconstruction vs. Fusion: Beyond Rigid vs. Flexible - Michael P. Clare, MD
  • I’ve Corrected Their Deformity... and They Still Hurt - Jonathan T. Deland, MD
  • Discussion

• • Ankle Fracture and Syndesmosis: Is the Sky Really Falling Down? - Daniel Guss, MD, MBA
  • Talus Fracture 360 - Nicholas L. Strasser, MD
  • Lisfranc Injuries: Beyond Fixing vs Fusing - Thomas G. Harris, MD

A need for this educational activity has been determined based on previous course evaluations and the AOFAS educational curriculum. The content of this course was based on current issues and topics provided by AOFAS membership and leadership. For more information on the AOFAS CME mission, visit aofas.org/education.

AOFAS requires all instructors, planners, and other individuals in a position to control or influence the content of an educational activity to disclose all relevant financial relationships or affiliations during the past 12 months with any commercial interest (any entity producing, marketing, re-selling, or distributing healthcare goods and services consumed by, or used on patients). All identified conflicts of interest must be resolved and the education content vetted by AOFAS for fair balance, scientific objectivity, and appropriateness. AOFAS also requires faculty to disclose when off-label/unapproved uses of a product are discussed in a CME activity. AOFAS attests that the persons responsible for the development of this educational activity did so independently and were not influenced by commercial supporters. All financial disclosures will be provided to meeting attendees in the final program materials.

The material presented in this continuing medical education activity has been made available by the American Orthopaedic Foot & Ankle Society (AOFAS) for educational purposes only. This material is not intended to represent the only, nor necessarily the best, methods or procedures appropriate for the medical situation discussed, but rather is intended to present an approach, view, statement, or opinion of the authors or presenters, which may be helpful or of interest to other practitioners. Methods, techniques, and procedures demonstrated and views and opinions expressed by speakers, presenters, and faculty are their own, and do not necessarily represent those of AOFAS, nor does presentation on the program represent or constitute endorsement or promotion by AOFAS. AOFAS expressly disclaims any warranties or guarantees, expressed or implied, and shall not be liable for damages of any kind in connection with the material, methods, information, techniques, opinions, or procedures expressed, presented, or demonstrated.

FDA Statement
Some drugs or medical devices demonstrated at this meeting have not been cleared by the FDA or have been cleared by the FDA for specific purposes only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or medical devices he or she wishes to use in clinical practice. AOFAS policy provides that “off label” uses of a drug or medical device may be described in its CME activities so long as the “off label” use of the drug or medical device is also specifically disclosed (i.e., it must be disclosed that the FDA has not cleared the drug or device for the described purpose). Any drug or medical device is being used “off label” if the described use is not set forth on the products approval label.

Faculty/Planner Disclosure Declaration
As an Accreditation Council for Continuing Medical Education (ACCME) provider, AOFAS has the obligation to ensure the delivery of education that is balanced and free of commercial bias. To achieve this, it is the policy of the AOFAS that all CME-related board members, committee members (“planners”), faculty, and appropriate staff disclose in writing to the learners’ all financial relationships that you have had in the past 24 months with ineligible companies. An “ineligible company” are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

In addition to faculty members, commentators from the floor are charged with verbally disclosing any interests immediately prior to speaking. All disclosures are provided in this final program distributed at the meeting to all program participants.

In accordance with AOFAS policy:
Faculty participation in this educational activity will be predicated upon timely submission and review of AOFAS disclosure. An individual who refuses to disclose all financial relationships will be disqualified from being a planning committee member, a teacher, or an author of CME, and cannot have control of, or responsibility for, the development, management, presentation, or evaluation of the CME activity. Non-compliance will result in a faculty member being stricken from the program.

An indication of the participant’s disclosure appears after his or her name as well as the ineligible company that provided the support. AOFAS does not view the existence of these disclosed interests or commitments as necessarily implying bias or decreasing the value of the author’s participation in this activity. In addition to ensuring that presentations be free of bias, faculty members are required to ensure that all material presented and discussed will be based on best- available evidence.